Pro-Dostinex 1 - Beligas Pharmaceuticals

As an ergot derivative, Cabergoline’s structure is instrumental in its selective prolactin inhibition. Its unique chemical makeup allows it to bind specifically to dopamine D2 receptors, avoiding the broader hormonal effects of less selective agents. This selectivity makes it more tolerable for patients needing long-term prolactin regulation. Cabergoline’s structure also contributes to its tolerability in diverse therapeutic applications, where hormone-specific action is required without the systemic side effects seen in older, less selective prolactin inhibitors​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Pro-Dostinex 1 by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.